✦ LIBER ✦

Albumin dialysis using the MARS as a treatment of end stage liver disease and progressive cholestasis

✍ Scribed by Jan Stange; Tarek I. Hassanein

Book ID: 119391279
Publisher: Nature Publishing Group
Year: 2001
Tongue: English
Weight: 24 KB
Volume: 96
Category: Article
ISSN: 0002-9270
DOI: 10.1016/s0002-9270(01)03169-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

161 Albumin dialysis using the MARS® sys

161 Albumin dialysis using the MARS® system in the treatment of patients with end-stage liver disease and renal failure

✍ F. Saliba; P. Ichai; M. Belnard; D. Azoulay; R. Adam; D. Castaing; D. Samuel 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Octreotide and albumin infusion in the t

Octreotide and albumin infusion in the treatment of decompensated end stage liver disease and oliguria

✍ Tarek I. Hassanein; Omaran Abdeen; Rhonda Martin; Ajai Khanna; Marquis Hart; Rav 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 27 KB

130 Applicability and safety of extracor

130 Applicability and safety of extracorporeal liver support using albumin dialysis (MARS) in the setting of liver transplantation

✍ M.-V. Catalina; C. Ripoll; G. Clemente; M. Salcedo; D. Rincon; A. Matilla; O. Nu 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 247 KB

Review of Combination of Peritoneal Dial

Review of Combination of Peritoneal Dialysis and Hemodialysis as a Modality of Treatment for End-stage Renal Disease

✍ PD + HD Combination Therapy Study Group 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

The pediatric end-stage liver disease (P

The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipients

✍ Neal R. Barshes; Timothy C. Lee; Ian W. Udell; Christine A. O'Mahoney; Saul J. K 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB 👁 1 views

The pediatric end-stage liver disease (PELD) model accurately estimates 90-day waitlist mortality for pediatric liver transplant candidates, but it has been unclear if PELD can identify patients who will derive survival benefit from undergoing liver transplantation (LT), if it correlates with posttr

Features associated with treatment failu

Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease

✍ Aldo J. Montano-Loza; Herschel A. Carpenter; Albert J. Czaja 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

Autoimmune hepatitis may fail to respond to corticosteroid therapy, but the frequency and bases for this outcome are uncertain. We aimed to determine the frequency and nature of treatment failure in patients with type 1 autoimmune hepatitis, define features associated with its occurrence, and assess